Clinical Trial

Muscle Oxygen Saturation and Functional Capacity in Breast Cancer Survivors

Not Yet Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated May 16, 2025 (before its estimated May 31, 2025 completion). Its status may not reflect the trial's current state.
Summary
This cross-sectional observational study aims to assess muscle oxygen saturation (SmO2) in the intercostal, quadriceps, and triceps surae muscles using near-infrared spectroscopy (NIRS) during functional exercise tests in breast cancer survivors. Participants will be grouped based on their previous cancer treatment: hormonal therapy only or hormonal therapy combined with chemotherapy. Functional performance will be evaluated through the 6-Minute Walk Test, 30-Second Sit-to-Stand Test, and a submaximal treadmill test. The study will analyze differences in muscle oxygenation and performance between groups and explore associations with other functional and clinical parameters.
Trial Details
NCT Number NCT06976593
Lead Sponsor University of Extremadura
Conditions Breast Cancer Survivorship, Muscle Oxygenation, Near-infrared Spectroscopy, Exercise, Quality of Life, Functional Capacity, Hormonal Therapy
Enrollment 30 participants
Start Date 2025-05-05
Primary Completion 2025-05-31 (estimated)
Study Completion 2025-05-31 (estimated)
Updated on ClinicalTrials.gov 2025-05-16